Thomas Williams

Big conductance calcium‐activated potassium channel openers control spasticity without sedation

A. Irving, G. Giovannoni, S. Jackson, 2017, British journal of pharmacology.

IgG4-related disease: a rare but treatable cause of refractory intracranial hypertension

G. Giovannoni, M. Marta, Thomas Williams, 2015, Practical Neurology.

The Outlook for Alemtuzumab in Multiple Sclerosis

A. Coles, L. Azzopardi, T. Williams, 2013, BioDrugs.

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

S. Ourselin, F. Barkhof, D. MacManus, 2020, The Lancet Neurology.